Melanoma Inhibitory Activity (MIA): A Serological Marker for Metastatic Uveal Melanoma
NCT00406900
·
clinicaltrials.gov ↗
UNKNOWN
Status
560
Enrollment
OTHER
Sponsor class
Conditions
Melanoma
Radiotherapy
Metastatic Disease
Interventions
PROCEDURE:
Treatment of metastatic disease
Sponsor
Ludwig-Maximilians - University of Munich